Guy van Hazel
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 27
- Cancer Treatment and Pharmacology 16
- Pancreatic and Hepatic Oncology Research 11
- Colorectal Cancer Surgical Treatments 5
- Cancer Research top 2%
- Breast Cancer Treatment Studies 6
-
- Gastric Cancer Management and Outcomes 10
-
- Radiomics and Machine Learning in Medical Imaging 6
- Co-authors
- Bruce N. GrayNiall C. TebbuttJohn ZalcbergTimothy PriceDongsheng TuPaul MorozChristos S. KarapetisDerek J. Jonker
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (11 papers)British Journal of Cancer (5 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Guy van Hazel
65 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Hepatology 1.1k
- Oncology 3.7k
- Cancer Research 894
- Pulmonary and Respiratory Medicine 1.8k
- Pathology and Forensic Medicine 637
Countries citing papers authored by Guy van Hazel
This map shows the geographic impact of Guy van Hazel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy van Hazel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy van Hazel more than expected).
Fields of papers citing papers by Guy van Hazel
This network shows the impact of papers produced by Guy van Hazel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy van Hazel. The network helps show where Guy van Hazel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guy van Hazel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2019 | 0 | |
| 3 | 2018 | 13 | |
| 4 | 2017 | 12 | |
| 5 | 2017 | 1 | |
| 6 | 2017 | 7 | |
| 7 | 2017 | 9 | |
| 8 | 2016 | 5 | |
| 9 | 2014 | 23 | |
| 10 | 2013 | 1 | |
| 11 | 2013 | 4 | |
| 12 | Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET) | 2012 | 4 |
| 13 | 2007 | 65 | |
| 14 | Cetuximab for the Treatment of Colorectal Cancerbreakdown → | 2007 | 1413 |
| 15 | 2003 | 222 | |
| 16 | 2001 | 25 | |
| 17 | 1999 | 4 | |
| 18 | 1998 | 181 | |
| 19 | 1989 | 27 | |
| 20 | 1983 | 6 |
About Guy van Hazel
Guy van Hazel is a scholar working on Oncology, Hepatology and Cancer Research, having authored 66 papers that have together received 5.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (27 papers), Cancer Treatment and Pharmacology (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Pancreatic and Hepatic Oncology Research (11 papers), Gastric Cancer Management and Outcomes (10 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Breast Cancer Treatment Studies (6 papers) and Colorectal Cancer Surgical Treatments (5 papers). The work is most often cited by research in Hepatology (1.1k citations), Oncology (3.7k citations) and Cancer Research (894 citations). Guy van Hazel has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Bruce N. Gray, Niall C. Tebbutt, John Zalcberg, Timothy Price, Dongsheng Tu, Paul Moroz, Christos S. Karapetis, Derek J. Jonker, Malcolm J. Moore and Chris J. O’Callaghan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Journal of Surgical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.